Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials

By Katie Garner, Advisor - Therapeutic Areas

Clinical trials increasingly rely on standardized data collection, particularly for patient-reported outcomes (PRO). Mobile technologies, notably smartphones, have emerged as crucial tools for gathering data from trial participants. While much attention has been on the bring-your-own-device (BYOD) model, where participants use their own smartphones, a significant portion of studies still opt for a provisioned device approach. However, the turnover of consumer devices presents challenges for ePRO providers.

Non-consumer smartphones, like the Santok STK, offer a solution due to their global reach, consistent performance, and longevity. Usability testing revealed favorable results, with the Santok STK meeting technical performance and usability criteria. This underscores its potential as a reliable tool for home-based ePRO measure administration in clinical trials. As Signant Health's Senior Manager of Site and Patient Research, see why I'm optimistic about integrating non-consumer devices to enhance data collection efficiency and compliance.